Escitalopram Unicorn 5, 10, 15, 20 5 mg, 10 mg, 15 mg and 20 mg FC tablets.
PDF Leaflet Revision Date: 01 August 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive episodes and panic disorder.
Dosage (summary)
10 mg daily for depression; 5 mg daily for the first week in panic disorder, then 10 mg.
Onset of Action / Duration
Onset: 2-4 weeks, Duration: up to 6 months.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; excreted in breast milk.
Key Drug Interactions
- MAOIs
- Serotonergic drugs
- Alcohol
- Anticoagulants
Contraindications
- Hypersensitivity to escitalopram
- QT interval prolongation
- Concurrent use with MAOIs
Common side effects
- Nausea
- Insomnia
- Dizziness
- Sexual dysfunction
Counselling Points
- Monitor for worsening depression or suicidality
- Avoid alcohol
- Gradual withdrawal recommended
Serious warnings
- Increased risk of suicidal thoughts
- QT interval prolongation
- Serotonin syndrome
Important Disclaimer
The Escitalopram Unicorn 5, 10, 15, 20 5 mg, 10 mg, 15 mg and 20 mg FC tablets. professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
